Immunecheckpoint expression in EpsteinBarr virus positive and negative
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients by Camille Laurent, Bettina Fabiani, Catherine Do, Emmanuelle Tchernonog, Guillaume Cartron, Pauline Gravelle, Nadia Amara, Sandrine Malot, Maryknoll Mawanay Palisoc, Christiane Copie-Bergman, Alexandra Traverse Glehen, Marie. Christine Copin, Pierre Brousset, Stefania Pittaluga, Elaine S. Jaffe, and Paul Coppo haematol Volume 101(8): 976 -984 July 31, 2016 © 2016 by Ferrata Storti Foundation
Clinical data in 82 plasmablastic lymphoma patients. Camille Laurent et al. Haematologica 2016; 101: 976 -984 © 2016 by Ferrata Storti Foundation
Immunophenotype and FISH rearrangement studies in Epstein-Barr virus (EBV)+ and EBV− plasmablastic lymphomas. Camille Laurent et al. Haematologica 2016; 101: 976 -984 © 2016 by Ferrata Storti Foundation
Immunohistochemical analysis of immune checkpoints in plasmablastic lymphomas (PL). Camille Laurent et al. Haematologica 2016; 101: 976 -984 © 2016 by Ferrata Storti Foundation
Immune checkpoint score in Epstein-Barr virus (EBV)+ and EBV− plasmablastic lymphoma immune cells. Camille Laurent et al. Haematologica 2016; 101: 976 -984 © 2016 by Ferrata Storti Foundation
Rates of infiltrating immune cells expressing immune escape markers in Epstein-Barr virus (EBV)+ versus EBV− plasmablastic lymphomas (PL). Camille Laurent et al. Haematologica 2016; 101: 976 -984 © 2016 by Ferrata Storti Foundation
Event-free survival in plasmablastic lymphoma (PL) patients. Camille Laurent et al. Haematologica 2016; 101: 976 -984 © 2016 by Ferrata Storti Foundation
- Slides: 7